Will Cannabis Genetics Be Banned?
The redefinition of hemp under federal law, set to take place Nov. 12, signals the loss of Farm Bill safeguards for numerous hemp-derived THC items across the nation: low-dose beverages as well as THCA flower and delta-8 THC edibles, vapes and additional products available at gas stops and smoke shops.
But the hemp ban also generates a significant complication for the legitimate cannabis sector. Seeds from cannabis varieties that produce flower with greater than 0.3% THC are no longer legal to transport out of state.
Although seed purchases will likely continue in legal states, the modifications threaten to close some seed banks and genetics businesses, observers say, while causing supply-chain issues for cannabis growers and retailers.
“If this language goes through, we will require pop-up shops to sell seeds in every state where it’s legal,” Campanella said. “Which is why we’re also providing clones and tissue cultivation, because that’s not covered in the bill.”
When are cannabis genetics and clones prohibited to ship across state lines?
The updated regulations categorize seeds based on the THC capacity of the mother plant. Genetic material such as seeds and clones are rendered illegal if the end product exceeds the threshold.
For now, seeds are currently shipping under the 2018 Farm Bill’s current quo. But the clock is ticking for businesses like Brothers Grimm and for cannabis growers who fear supply chain interruptions if out-of-state availability to genetics is prohibited.
Most of the cannabis industry remains mostly unaware of the impending shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.
Without government intervention in the form of an exception for seeds or a general moratorium, many seed suppliers will simply be shuttered by November, he added.
“We are functioning legally now, but if that changes, it will disrupt the legal licensed sector in each state,” said Power, whose clientele includes seed suppliers as well as licensed commercial cultivators.
“Customers are going to forfeit choice, and it will be a significant shutdown for most people.”
What are cannabis seed suppliers doing to remain legal after the federal hemp ban?
Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which strengthened cannabis oversight in that state while also limiting hemp-derived THC items to licensed cannabis retailers.
Previously a seed bank, Silberhaze is currently focused on the branding, preservation and IP protection of premium plant genetics.
That’s because seed businesses hoping to remain compliant in this updated environment must have solid documentation, he said.
“You have to prove where this stuff comes from, so it’s very important to have records, even to the extent where you have breeder names,” Silber said.
“Small businesses will have to work with improved records and a stronger chain of custody,” he added. “We want that documentation ourselves, because we don’t want to be dealing with shady sources.”
To prevent seizures and https://nativesusa.com/ (nativesusa.com) other legal fallout, seed business owners must “get their affairs in order” before the updated regulations take effect, Silber said.
“Audit all your materials immediately, and categorize what you can,” Silber said. “Take inventory, document your heritage, preserve cultivator records, and organize any cannabinoid or terpene information you currently have. If regulations shift, you’ll be in a much better position to understand what may be impacted and make educated decisions.”
Does government marijuana rescheduling affect cannabis genetics?
Silber believes U.S. Drug Enforcement Administration registration may be required for companies engaged in research.
But for now, seed companies can’t register with the DEA like state-licensed therapeutic cannabis businesses can. Such an option is not available to seed suppliers, nurseries or genetics companies, said Jim Ickes, a lawyer and partner with Frantz Ward’s cannabis law group in Cleveland.
“Seed-related activity may be happening inside larger state-licensed therapeutic marijuana businesses, as some states allow dispensaries or registered therapeutic operators to offer seeds, clones or personal growing materials,” he said.
“But that is distinct from the DEA creating a freestanding seed bank registration category.”
Some genetics companies are already changing operational practices to conform with the updated law. According to Ickes, they must address questions including:
- Which of our lines produce plants over 0.3% total THC?
- Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
- What does our inventory look like once we organize it against the genetics exclusion?
Ickes also understands confusion from clients who believed federal rescheduling of medical marijuana would resolve their situation with banking institutions. However, the latest regulatory wording has shifted those conversations beyond the basics of classification, he said.
“Banks ask whether this particular revenue stream is lawful, whether it connects to state-licensed activity, or whether there’s cross-state risk,” said Ickes.
“After November, a seed bank selling high-THC genetics can’t address the first question with the hemp definition. It has to refer to a lawful state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed maintain the simpler story.”
What’s the future of cannabis genetics?
Campanella is part of a emerging coalition of other breeders, farmers and researchers that’s arguing seeds are better defined as agricultural inputs than regulated substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, allowing the DEA to focus its enforcement efforts elsewhere.
“How do you regulate something based on what it could become one day?” said Campanella. “Our preference is to have that language removed, or get seeds regulated by the USDA as a hemp product.”
But in the meantime, Campanella is restructuring Brothers Grimm to function outside the scope of changing federal oversight. The business plans to keep its Colorado seed facility while positioning its Oklahoma tissue culture facility as a hedge against federal prohibition of cannabis seeds.
As she noted: “If things develop in a way where we can’t concentrate on interstate shipping, we’ll have additional resources to meet people’s requirements without putting ourselves in trouble.”